← back to search

Ketil Heimdal

Oslo University Hospital · NO
Area of research
Genetics · Surgery
Research interest
Research interests include BRCA gene mutations in cancer, Testicular diseases and treatments, Genetic factors in colorectal cancer, and Genomic variations and chromosomal abnormalities.
h-index
41
citations
7,558
works
156
NIH funding
primary concept
Medicine
email

Recent publications

Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules
Science 2024cited by 44position: middledoi
Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules.
2024cited by 37position: contributordoi
Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles
Human Genetics and Genomics Advances 2024cited by 11position: middledoi
<i>TUBB4B</i>variants specifically impact ciliary function, causing a ciliopathic spectrum
2022cited by 1position: contributordoi
Histological Features of Sporadic and Familial Testicular Germ Cell Tumors Compared and Analysis of Age-Related Changes of Histology
Cancers 2021cited by 8position: middledoi
Histological Features of Sporadic and Familial Testicular Germ Cell Tumors Compared and Analysis of Age-Related Changes of Histology.
2021cited by 4position: contributordoi
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
Annals of Internal Medicine 2020cited by 495position: middledoi
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
2020cited by 340position: contributordoi
Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis.
2019cited by 6position: contributordoi
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
Journal of Allergy and Clinical Immunology 2016cited by 278position: middledoi
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC–PGL syndromes: a clinicopathological and molecular analysis
European Journal of Endocrinology 2013cited by 139position: middledoi
Novel Mutations Including Deletions of the Entire<i>OFD1</i>Gene in 30 Families with Type 1 Orofaciodigital Syndrome: A Study of the Extensive Clinical Variability
Human Mutation 2012cited by 49position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Robert Huddart · Institute of Cancer Research2 papers (2021–2021) · 1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2021–2021)Mark H. Greene · University of Southern California1 papers (2021–2021)L. Sylvia · University of North Carolina at Chapel Hill1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2021–2021)Francien H. van Nederveen · Albert Schweitzer Ziekenhuis1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2013–2013)Andreas Stang · Landesinstitut für Arbeitsgestaltung des Landes Nordrhein-Westfalen1 papers (2021–2021)Elizabeth Rapley · Institute of Cancer Research1 papers (2021–2021)Mary L. McMaster · Cancer Genetics (United States)1 papers (2021–2021) · 1 papers (2021–2021)Katherine A. McGlynn · SpringerNature1 papers (2021–2021) · 1 papers (2021–2021)Winand N.M. Dinjens · AbbVie (United States)1 papers (2013–2013)Leo J. Hofland · University of Birmingham1 papers (2013–2013)